关注
Robert W. Cross, Ph.D, MPH
Robert W. Cross, Ph.D, MPH
在 utmb.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ...
Science translational medicine 13 (593), eabf1906, 2021
4032021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
K Westendorf, S Žentelis, L Wang, D Foster, P Vaillancourt, M Wiggin, ...
Cell reports 39 (7), 2022
3572022
Lassa fever in post-conflict Sierra Leone
JG Shaffer, DS Grant, JS Schieffelin, ML Boisen, A Goba, JN Hartnett, ...
PLoS neglected tropical diseases 8 (3), e2748, 2014
2482014
Establishment of an African green monkey model for COVID-19 and protection against re-infection
C Woolsey, V Borisevich, AN Prasad, KN Agans, DJ Deer, NS Dobias, ...
Nature immunology 22 (1), 86-98, 2021
2412021
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
JE Robinson, KM Hastie, RW Cross, RE Yenni, DH Elliott, JA Rouelle, ...
Nature communications 7 (1), 11544, 2016
1832016
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy
CCBTWG Chad E. Mire, Benjamin A. Satterfield, Joan B. Geisbert, Krystle N ...
Scientific Reports 6, 2016
1532016
Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses
T Farkas, RW Cross, E Hargitt III, NW Lerche, AL Morrow, K Sestak
Journal of virology 84 (17), 8617-8625, 2010
1502010
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
Nature Medicine, 2017
1292017
Post-exposure treatments for Ebola and Marburg virus infections
RW Cross, CE Mire, H Feldmann, TW Geisbert
Nature Reviews Drug Discovery, 2018
1202018
The immunomodulating V and W proteins of Nipah virus determine disease course
BA Satterfield, RW Cross, KA Fenton, KN Agans, CF Basler, TW Geisbert, ...
Nature communications 6 (1), 7483, 2015
1002015
The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
RW Cross, CE Mire, V Borisevich, JB Geisbert, KA Fenton, TW Geisbert
The Journal of infectious diseases 214 (4), 565-569, 2016
922016
A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates
ZA Bornholdt, AS Herbert, CE Mire, S He, RW Cross, AZ Wec, ...
Cell host & microbe 25 (1), 49-58. e5, 2019
902019
Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
CE Mire, KM Versteeg, RW Cross, KN Agans, KA Fenton, MA Whitt, ...
Virology journal 10, 1-13, 2013
882013
Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization
P Gilchuk, CD Murin, JC Milligan, RW Cross, CE Mire, PA Ilinykh, ...
Immunity 52 (2), 388-403. e12, 2020
812020
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
RW Cross, CE Mire, LM Branco, JB Geisbert, MM Rowland, ML Heinrich, ...
Antiviral Research, 2016
772016
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
RW Cross, KN Agans, AN Prasad, V Borisevich, C Woolsey, DJ Deer, ...
Virology journal 17, 1-12, 2020
672020
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death
RW Cross, R Xu, D Matassov, S Hamm, TE Latham, CS Gerardi, ...
The Journal of Clinical Investigation 130 (1), 539-551, 2020
582020
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
TW Rodriguez, Sergio E., Cross, Robert W., Fenton, Karla A. Bente, Denis A ...
Scientific Reports 9, 2019
572019
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
ML Boisen, JN Hartnett, JG Shaffer, A Goba, M Momoh, JD Sandi, ...
Scientific reports 8 (1), 5939, 2018
542018
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever
JM Fels, DP Maurer, AS Herbert, AS Wirchnianski, O Vergnolle, RW Cross, ...
Cell 184 (13), 3486-3501. e21, 2021
532021
系统目前无法执行此操作,请稍后再试。
文章 1–20